New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With …
PARSIPPANY, N.J., April 23 /PRNewswire/ — Results of a new study showed that Welchol® (colesevelam HCl) 3.75 g/d significantly improved lipid and glycemic measures in patients with high LDL cholesterol and prediabetes (impaired fasting glucose and/or impaired glucose tolerance).

Read more on redOrbit